Three industry leading companies, MedQIA, WorldCare Clinical and DARC, have come together to form Voiant, the new leader in clinical trial imaging endpoint data. We are the industry leading AI-based clinical trial imaging solution with unparalleled scientific and clinical domain expertise, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data. We combine leadership in artificial intelligence and visionary computing, key opinion leaders for strategic therapeutic areas alignment and clinical research experts to deliver operational excellence and consistent execution - providing the shortest path to the highest quality imaging data for clinical trials.
| Website | https://www.voiantclinical.com/ |
| Revenue | $29.4 million |
| Employees | 116 (103 on RocketReach) |
| Address | 135 Beaver St Suite 208, Waltham, Massachusetts 02452, US |
| Industry | Hospitals and Health Care |
| Keywords | Medical Image Analysis, Clinical Trial Technology, Image Data Analysis, Medical Imaging Software, Medical Image Analysis Software, Healthcare Ai, Ai Image Processing, Ai Medical Imaging, Clinical Trial Data, Digital Health Technology, Clinical Trial Solutions, Biomedical Imaging, Data Analytics Healthcare, Drug Development, Diagnostic Imaging, Patient Monitoring |
| Competitors | Oracle Health Information, Siemens, McKesson, Xerox, athenahealth, CLINICAL REVIEW SOLUTIONS LTD, MEDITECH, Epic, eClinicalWorks, NextGen Healthcare +39 more (view full list) |
Looking for a particular VOIANT℠ employee's phone or email?
The VOIANT℠ annual revenue was $29.4 million in 2026.
James Primerano is the CEO of VOIANT℠.
103 people are employed at VOIANT℠.
VOIANT℠ is based in Waltham, Massachusetts.